GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aurobindo Pharma Ltd (BOM:524804) » Definitions » Construction In Progress

Aurobindo Pharma (BOM:524804) Construction In Progress : ₹0 Mil (As of Dec. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Aurobindo Pharma Construction In Progress?

Aurobindo Pharma's quarterly construction in progress increased from Jun. 2024 (₹0 Mil) to Sep. 2024 (₹34,966 Mil) but then declined from Sep. 2024 (₹34,966 Mil) to Dec. 2024 (₹0 Mil).

Aurobindo Pharma's annual construction in progress increased from Mar. 2022 (₹30,415 Mil) to Mar. 2023 (₹48,082 Mil) but then declined from Mar. 2023 (₹48,082 Mil) to Mar. 2024 (₹28,662 Mil).

Aurobindo Pharma Construction In Progress Historical Data

The historical data trend for Aurobindo Pharma's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurobindo Pharma Construction In Progress Chart

Aurobindo Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17,877.20 24,288.90 30,414.80 48,082.20 28,661.80

Aurobindo Pharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 28,661.80 - 34,966.00 -

Aurobindo Pharma Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Aurobindo Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aurobindo Pharma Ltd (BOM:524804) » Definitions » Construction In Progress
Comparable Companies
BOM:500488 NSE:ALKEM BOM:532321 BOM:500257 BOM:500124 BOM:532296 BOM:543904 BOM:524494 BOM:540222 BOM:532331 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
AUROPHARMA:India
Address
Plot No. 1, Survey No. 83/1, Galaxy, Floors 22-24, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad, TG, IND, 500032
Website
https://www.aurobindo.com
Aurobindo Pharma Ltd is a specialty and generic drug manufacturing company. It is principally engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Its formulations target key therapeutic areas, including Central Nervous System (CNS), Antibiotics, Anti-diabetics, Cardiovascular, Anti-retroviral, Gastroenterology, Oncology, and Dermatology. The operating and reportable segments of the company are; India, the United States of America, Europe, and the Rest of the World. The company generates a majority of its revenue from its business in the United States of America.

Aurobindo Pharma Headlines

No Headlines